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ABSTRACT
Introduction: Clinical quality indicators are necessary
to monitor the performance of healthcare services. The
development of indicators should, wherever possible,
be based on research evidence to minimise the risk of
bias which may be introduced during their
development, because of logistic, ethical or financial
constraints alone. The development of automated
methods to identify the evidence base for candidate
indicators should improve the process of indicator
development. The objective of this study is to explore
the relationship between clinical quality indicators for
asthma management in children with outcome and
process measurements extracted from randomised
controlled clinical trial reports.
Methods and analysis: National-level indicators for
asthma management in children will be extracted from
the National Quality Measures Clearinghouse (NQMC)
database and the National Institute for Health and Care
Excellence (NICE) quality standards. Outcome
measures will be extracted from published English
language randomised controlled trial (RCT) reports for
asthma management in children aged below 12 years.
The two sets of measures will be compared to assess
any overlap. The study will provide insights into the
relationship between clinical quality indicators and
measurements in RCTs. This study will also yield a list
of measurements used in RCTs for asthma
management in children, and will find RCT evidence
for indicators used in practice.
Ethics and dissemination: Ethical approval is not
necessary because this study will not include patient
data. Findings will be disseminated through peer-
reviewed publications.
INTRODUCTION
The drive to improve the quality and safety
of healthcare has resulted in the prolifer-
ation of clinical quality indicators. Indicators
may be used to assess the quality of care, or
to identify and prioritise areas for improve-
ment.1 2 They describe “as much about a
system as possible in as few points as
possible”.3
A good indicator should be important,
relevant, valid, reliable, meaningful and
understandable.3 4 In addition, indicators
should be easy to collect,5 and the costs of
doing so should not outweigh the potential
beneﬁts.6 The development of indicators can
be complex and resource intensive.
Indicators can be developed using deductive
approaches (moving from target concepts to
supporting data), inductive approaches
(using data to identify concepts) or both.7
Deductive approaches are more common.7
The steps to developing indicators deduct-
ively are: (1) selecting a topic, (2) forming a
review team, (3) researching the evidence
and practice behind candidate indicators,
(4) selecting indicators, (5) designing their
speciﬁcations, (6) pilot testing their collec-
tion and (7) implementing them.2 8
In practice, clinical indicators can be vul-
nerable to bias and lack rigour8 because of
(sometimes necessary) logistic, ethical or
ﬁnancial constraints during their develop-
ment. To minimise these risks, the develop-
ment of indicators should, wherever possible,
be based on research evidence.2 9 Different
grades of evidence are available, and
Strengths and limitations of this study
▪ Develop a novel method for comparing indicators
with research evidence in clinical trial.
▪ Provide a systematic and objective way to iden-
tify candidate indicators, identify research asso-
ciated with current indicators, and identify
potential inconsistencies between research evi-
dence and clinical practice.
▪ Generate a list of measurements used in rando-
mised controlled trials of asthma management in
children.
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randomised controlled trials (RCT) are generally
regarded as one of the highest levels of evidence.10 11
Asthma is a chronic respiratory disease that affects
about 300 million people globally, with an estimated
250 000 deaths annually.12 It is the most common
chronic disease among children. There is currently no
cure for asthma, but it can generally be managed and
controlled with appropriate care (care regarded as
being in line with clinical guidelines13–15). Many quality
indicators have been developed for asthma;16–20 most
are based on clinical practice guidelines (CPGs). For
example, the National Institute for Health and Care
Excellence (NICE) quality standards for asthma are
based on the British Thoracic Society/Scottish
Intercollegiate Guidelines Network (BTS/SIGN) clinical
guideline 101: British guidelines on the management of
asthma;13 and the asthma clinical performance measure-
ment tool promoted by the Physician Consortium for
Performance Improvement is based on the National
Asthma Education and Prevention Program Expert
Panel Report 2.21
To better assess the level of evidence behind currently
recommended indicators, this protocol describes a study
of the relationship between outcome measurements
used in RCTs and national level clinical quality indica-
tors in the UK and the USA, using asthma management
in children as a case study. The study will compare
outcome terms extracted from RCT reports with clinical
quality indicators by assigning concepts from the
Uniﬁed Medical Language System (UMLS) using
MetaMap22 to both sets of terms. This allows terms from
different sources to be standardised for easy aggregation
and comparison. MetaMap has been used for many
tasks, for example, information retrieval23 and text
mining,24 25 and has been shown to perform well in
mapping biomedical concepts to text compared with
human labelling.26
METHODS AND ANALYSIS
The study will examine asthma management in children
aged less than 12 years. There are four basic steps: (1)
identiﬁcation and extraction of indicators, (2) identiﬁca-
tion and extraction of outcome measurements from
RCTs, (3) mapping both sets of metrics to underlying
concepts as deﬁned in the UMLS using MetaMap and
(4) matching and comparing clinical quality indicators
and RCT measurements, with an evaluation of the basis
for any differences.
Identification and extraction of indicators
National-level clinical quality indicators for asthma man-
agement in children from the USA and the UK will be
collected. The National Quality Measures Clearinghouse
(NQMC) is a database on healthcare quality measures
sponsored by the US Department of Health and Human
Services—Agency for Healthcare Research and Quality
(AHRQ). The NQMC will be searched using the term
‘asthma’ within the respiratory tract diseases condition
(50 measures in asthma of the 243). The NICE quality
standard for asthma (11 asthma quality standards) will
also be included. NICE plays a major role in commission-
ing and producing guidelines and developing quality
standards for Britain’s National Health Service (NHS).
The following inclusion criteria will be used to select
indicators:
1. Any process or outcome indicator,
2. Any indicator of pharmacological or non-
pharmacological management,
3. Applicable to children aged below 12 years,
4. Developed for national-level assessment.
Candidate indicators identiﬁed in the search will be
independently assessed against inclusion criteria by two
appraisers. Disagreements will be resolved by consensus.
The included indicators will then be normalised as
follows:
1. Remove: Unit of analysis (eg, number of people/
patients),
2. Remove: Time points/frames (eg, more than 24 h,
within 2 days) for a process to occur,
3. Remove: The term “asthma” if it describes the
characteristics of patients,
4. Extract: Noun terms describing the unit of analysis
(examples in table 1).
Table 2 shows examples of possible terms that may be
extracted from the indicator sources.
Identification and extraction of outcomes from RCTs
Types of studies
Only RCTs will be included. Secondary/post hoc ana-
lysis/protocol of RCTs will be excluded.
Types of participants
Children with asthma aged below 12 years will be
included.
Types of interventions
Studies that involved any type of medical or non-medical
management of asthma will be included.
Search strategy
We will search PubMed for RCTs on asthma manage-
ment for children aged below 12 years. Studies will be
restricted to English language articles published in the
past 10 years (2005–2014).




Hospitalisation, asthma action plan
Medication Steroids, inhaled corticosteroids,
leukotriene inhibitors
Event Exacerbation of asthma
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The following search terms will be used to retrieve
PubMed articles:
1. Asthma
2. (randomised controlled trial[Publication Type] OR
(randomised[Title/Abstract] AND controlled[Title/
Abstract] AND trial[Title/Abstract]))
3. #1 AND #2
4. #3 AND “English”[Language]
The second search term above is the speciﬁc/narrow
therapy ﬁlter for clinical queries. PubMed ﬁlters of
Species (‘Humans’) and Ages (‘Infant: birth-23 months’,
‘Preschool Child: 2–5 years’, and ‘Child: 6–12 years’) will
be applied.
Study selection
The titles and abstracts of the resulting references will
be screened independently by two reviewers against the
following inclusion criteria:
1. Articles describing RCT, excluding secondary/post
hoc analysis/protocol of RCTs;
2. The participants of the trial include children with
asthma aged below 12 years even if the trial also
includes other participants;
3. The trial’s focus is on medical or non-medical man-
agement of asthma.
Any control arm is acceptable as well as any outcome
measure. Disagreements will be resolved by consensus.
Inter-rater agreement will be measured periodically on
screening decisions and only one screener may be used
for the remaining abstracts if agreement is high (ie,
Cohen’s κ>0.8).27
The full text of the potentially eligible studies will be
retrieved and reassessed if the abstract does not contain
enough information to make a decision.
Outcome measures extraction from clinical trials and
ambiguities resolution
RCTs generally report using the PICO criteria:28
Population, Intervention, Comparison, and Outcome. Two
independent annotators will be asked to independently
extract the Population (ie, number of participants in the
study) and Outcome (outcome names) from the full text
of every included RCT. Outcome terms will be any
phrase that describes a quantiﬁable measurement.
Outcome names identiﬁed by this process will be nor-
malised using the following rules:
1. Outcome deduplication: Similar outcome terms men-
tioned multiple times in an RCT will only be consid-
ered as a single occurrence.
2. Generalisation relationships: The most speciﬁc term
mentioned in an RCT will be preferred. For example,
spirometry and peak ﬂow measurement both describe
lung function tests, but the latter is more speciﬁc.
3. Ambiguities: Any ambiguities will be resolved by con-
sultation with a paediatric respiratory physician,
paediatric nurse or other relevant clinician.
Inter-rater agreement will be measured periodically on
extraction decisions and only one extractor may be used
for the remaining extractions if agreement is high (ie,
Cohen’s κ>0.8).
UMLS concept mapping using MetaMap
The list of terms extracted from indicator sources and
the list of outcome measures taken from RCTs will next
both be mapped into standardised terms (UMLS con-
cepts using MetaMap) to facilitate aggregation and com-
parison. The UMLS Metathesaurus, from the National
Library of Medicine, comprises over 1 million biomed-
ical concepts from over 100 source vocabularies.
Table 2 Examples of terms extracted from clinical indicators
Extracted terms Classification
Paediatric inpatients with asthma who received relievers
during hospitalisation
Relievers; hospitalisation Medication; type of
recommended care
Paediatric inpatient discharge, age 2 years through
17 years, with an International Classification of
Diseases, Ninth Revision, Clinical Modification
(ICD-9-CM) Principal Diagnosis Code of asthma
Inpatient discharges Type of recommended care
Number of patients with asthma who have an asthma
discharge plan
Asthma discharge plan Type of recommended care
Number of patients with asthma who were seen in an




Type of recommended care;
type of recommended care
The number of people in the denominator followed up by
their own GP practice within 2 working days of
treatment
GP practice Type of recommended care
The number of people who received treatment in
hospital or through out-of-hours services for an acute
exacerbation of asthma
Hospital; out-of-hours services;
acute exacerbation of asthma
Type of recommended care;
type of recommended care;
event
Bold typeface indicates ‘extracted terms’.
GP, general practitioner.
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MetaMap22 is a tool for mapping biomedical terms in
free text to the UMLS Metathesaurus. MetaMap will be
provided with extracted terms from clinical indicators
and RCTs and will return a list of ranked mapping
options. We will use all concepts identiﬁed by MetaMap
in this study. If no UMLS concept is found, we will
retain the extracted term. Table 3 shows examples of
phrases mapped to UMLS terms. As shown in table 3,
‘exacerbation of asthma’ will be mapped to ‘asthma
exacerbation’ and ‘PEF’ will be mapped to ‘peak expira-
tory ﬂow’ even if they are expressed differently.
Extracted term ranking
UMLS concepts will be ranked according to the total
number of RCT participants that they were applied to.
In most cases, this is the number of patients randomised
or for whom there was an intention to treat.
Mapping and comparing clinical quality indicators and
RCT measurements
The RCT outcomes and practice indicators will then be
compared using UMLS concepts by two annotators.
Terms in both lists will be mapped to each other if one
or more UMLS concepts associated with them match.
The mappings will be agreed by consensus and inter-
rater reliability will be measured. Advice will be sought
from appropriate clinicians if consensus cannot be
reached.
The congruence between the mapped outcomes from
RCTs and those from clinical indicators will be mea-
sured. Measured outcomes in RCT that are not used as
clinical indicators may imply wastage either because
metrics with research evidence behind them are not
being used as indicators, or because clinical trials have
measured outcomes that are not important in the assess-
ment of routine care. Indicators that cannot be mapped
to outcomes in RCTs will also be identiﬁed as they may
have little or no research evidence to support their use.
DISCUSSION
This protocol describes a novel method for comparing
indicators with research evidence in clinical trials, and
will help to determine if indicators associated with the
management of asthma in children are supported by
research evidence. This study will also generate a list of
measurements used in RCTs of asthma management in
children.
A limitation is that it will not examine other levels of
evidence beyond level 1 (RCT) evidence. Some indica-
tors may not be appropriate for use in RCTs and may
appear in different study types, such as economic evalua-
tions. Further, the protocol does not investigate if the
RCTs support the use of indicators, and only looks for
evidence of their use as a proxy indicator of utility.
Some RCT outcomes may be important in early phases
of the evaluation of an intervention, but will have
limited application in routine practice. This study is also
limited by searching only PubMed and assessing only
English language RCTs.
However, it is important because it provides a systematic
and objective way of ﬁnding candidate level 1 evidence
for clinical indicators. It will assist in identifying candi-
date indicators, identifying research associated with
current indicators, and identifying potential inconsisten-
cies between research evidence and clinical practice.
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Table 3 Examples of mapping to UMLS terms using MetaMap
Phrases UMLS mapping by MetaMap
Exacerbation of asthma C0349790:Exacerbation of asthma [Finding]
C0004096:–Asthma (Asthma) [Disease or Syndrome]
C2984299:Asthma (Asthma Pathway) [Functional Concept]
Asthma exacerbation C0349790:asthma exacerbation (Exacerbation of asthma) [Finding]
C0004096:–Asthma (Asthma) [Disease or Syndrome]
C2984299:Asthma (Asthma Pathway) [Functional Concept]
PEF C0030771:PEF (Pefloxacin) [Antibiotic,Organic Chemical]
C1518922:PEF (Peak Expiratory Flow) [Laboratory Procedure]
C1542834:PEF (Peak expiratory flow rate) [Finding]
Peak expiratory flow C1518922:Peak Expiratory Flow [Laboratory Procedure]
C0857465:peak flow [Finding]
C0231800:Expiratory (Expiration, function) [Organ or Tissue Function]
C0444505:Peak (Peak level) [Quantitative Concept]
C0806140:Flow (flow) [Natural Phenomenon or Process]
UMLS, Unified Medical Language System.
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